Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 0 | -720 | 0 | 306 |
| Gross Profit | N/A | N/A | -720 | N/A | 306 |
| Operating Expenses | 1,865 | 3,275 | -13,115 | 4,518 | 13,739 |
| Operating Income | -1,865 | -3,275 | 12,395 | -4,518 | -13,433 |
| Other Income | 62 | 88 | 132 | 111 | 45 |
| Pre-tax Income | -1,803 | -3,187 | 12,527 | -4,407 | -13,388 |
| Net Income Continuous | -1,803 | -3,187 | 12,527 | -4,407 | -13,388 |
| Net Income Discontinuous | -2,378 | -3,767 | -19,743 | -6,089 | N/A |
| Net Income | $-4,181 | $-6,954 | $-7,216 | $-10,496 | $-13,388 |
| EPS Basic Total Ops | -1.83 | -3.20 | -3.29 | -4.83 | -6.16 |
| EPS Basic Continuous Ops | -0.79 | -1.46 | 5.77 | -2.03 | -6.16 |
| EPS Basic Discontinuous Ops | -1.04 | -1.73 | -9.09 | -2.80 | N/A |
| EPS Diluted Total Ops | -1.83 | -3.20 | -3.29 | -4.83 | -6.16 |
| EPS Diluted Continuous Ops | -0.79 | -1.46 | 5.77 | -2.03 | -6.16 |
| EPS Diluted Discontinuous Ops | -1.04 | -1.73 | -9.09 | -2.80 | N/A |
| EBITDA(a) | $-1,865 | $-3,275 | $12,395 | $-4,518 | $-13,416 |